the largest and only placebo-controlled trial to start therapy before operation showed that dipyridamole ( persantine ) plus aspirin markedly reduced occlusion ( compared with placebo ) in both high- and low-risk subgroups both early and at a median of 1 year after operation .
C0012582
dipyridamole
C0700020
persantine